{"product_id":"ara-290-value-bundle","title":"ARA-290 value bundle","description":"\u003cp\u003e\u003cstrong\u003eFour 10mg units of ARA-290 for extended neuropathy research protocols.\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eContains 4 x 10mg units of ARA-290.\u003c\/p\u003e\u003cp\u003eARA-290 is primarily studied for its role in protecting nerve tissue, modulating inflammation, and supporting cellular repair. It has shown potential in preclinical and early clinical research for applications involving neuropathic pain, metabolic dysfunction, and tissue injury. Its mechanism centers on reducing pro-inflammatory cytokine activity and promoting restoration of damaged cells, particularly within the nervous system.\u003c\/p\u003e\u003cp\u003eNeuropathic pain is dysfunction in the nervous system itself, not necessarily a product of an actual physical injury. This can show up as numbness, a burning sensation, pins and needles or an electric shock like phenomenon. Chronic pain like sciatica is but one example. ARA-290 was investigated for its role in disrupting these illusory pain signals.\u003c\/p\u003e\u003cp\u003eARA-290 is a synthetic peptide derived from a specific region of erythropoietin (EPO), engineered to selectively target the innate repair receptor (IRR) without stimulating red blood cell production. This design allows it to retain tissue-protective and anti-inflammatory signaling properties while avoiding the hematopoietic effects typically associated with EPO.\u003c\/p\u003e\u003ch4\u003eKey Features\u003c\/h4\u003e\u003cul\u003e\n\u003cli\u003eSelective activation of the innate repair receptor (IRR)\u003c\/li\u003e\n\u003cli\u003eNon-erythropoietic (does not increase red blood cell production)\u003c\/li\u003e\n\u003cli\u003eInvestigated for neuroprotective and anti-inflammatory effects\u003c\/li\u003e\n\u003cli\u003eShort peptide structure with targeted biological activity\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch4\u003eResearch Areas of Interest\u003c\/h4\u003e\u003cul\u003e\n\u003cli\u003eSmall fiber neuropathy and nerve repair\u003c\/li\u003e\n\u003cli\u003eChronic inflammation and inflammatory signaling pathways\u003c\/li\u003e\n\u003cli\u003eMetabolic and mitochondrial function\u003c\/li\u003e\n\u003cli\u003eTissue protection following injury or stress\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp\u003eARA-290 is typically supplied as a lyophilized powder for research purposes and requires reconstitution prior to use. Due to its investigational status, it is not approved for general medical use and is intended strictly for laboratory and research applications.\u003c\/p\u003e\u003cp\u003eEarly clinical data suggests a dose of 2-6mg per day for 2-4 weeks.\u003c\/p\u003e\u003cp\u003e\u003cem\u003e4 × 10mg ARA-290 · For laboratory and research use only. Not for human or animal consumption. 18+ qualified researchers only.\u003c\/em\u003e\u003c\/p\u003e","brand":"Eagle Research","offers":[{"title":"Default Title","offer_id":43101911515198,"sku":"ara-290-value-bundle","price":179.95,"currency_code":"AUD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0674\/1927\/5326\/files\/ara-290-value-bundle.png?v=1784359909","url":"https:\/\/eagleresearch.store\/products\/ara-290-value-bundle","provider":"Eagle Research","version":"1.0","type":"link"}